Buy or Sell ShockWave Medical Inc. (SWAV) Stock Now | Don’t Try to Be a Top Gun – News Heater
Home  »  Business   »  Buy or Sell ShockWave Medical Inc. (SWAV) Stock No...

Buy or Sell ShockWave Medical Inc. (SWAV) Stock Now | Don’t Try to Be a Top Gun

ShockWave Medical Inc. (NASDAQ:SWAV) went down by -15.58% from its latest closing price compared to the recent 1-year high of $249.73. The company’s stock price has collected -26.75% of loss in the last five trading sessions.

Is It Worth Investing in ShockWave Medical Inc. (NASDAQ :SWAV) Right Now?

The average price from analysts is $229.29, which is $113.38 above the current price. SWAV currently public float of 33.73M and currently shorts hold a 3.55% ratio of that float. Today, the average trading volume of SWAV was 416.03K shares.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored

SWAV’s Market Performance

SWAV stocks went down by -26.75% for the week, with a monthly drop of -45.86% and a quarterly performance of -22.97%, while its annual performance rate touched -14.01%. The volatility ratio for the week stands at 10.38% while the volatility levels for the past 30 days are set at 7.26% for ShockWave Medical Inc.. The simple moving average for the period of the last 20 days is -36.15% for SWAV stocks with a simple moving average of -37.99% for the last 200 days.

Analysts’ Opinion of SWAV

Many brokerage firms have already submitted their reports for SWAV stocks, with Wolfe Research repeating the rating for SWAV by listing it as a “Outperform.” The predicted price for SWAV in the upcoming period, according to Wolfe Research is $255 based on the research report published on April 06th of the current year 2022.

BofA Securities, on the other hand, stated in their research note that they expect to see SWAV reach a price target of $200. The rating they have provided for SWAV stocks is “Buy” according to the report published on March 02nd, 2022.

Wells Fargo gave a rating of “Overweight” to SWAV, setting the target price at $235 in the report published on December 06th of the previous year.

SWAV Trading at -36.27% from the 50-Day Moving Average

After a stumble in the market that brought SWAV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -53.59% of loss for the given period.

Volatility was left at 7.26%, however, over the last 30 days, the volatility rate increased by 10.38%, as shares sank -45.96% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -33.99% lower at present.

During the last 5 trading sessions, SWAV fell by -26.75%, which changed the moving average for the period of 200-days by -33.64% in comparison to the 20-day moving average, which settled at $176.60. In addition, ShockWave Medical Inc. saw -35.00% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at SWAV starting from Zacharias Isaac, who sale 619 shares at the price of $160.36 back on Apr 29. After this action, Zacharias Isaac now owns 65,221 shares of ShockWave Medical Inc., valued at $99,263 using the latest closing price.

Zacharias Isaac, the Chief Commercial Officer of ShockWave Medical Inc., sale 3,370 shares at $183.76 during a trade that took place back on Apr 26, which means that Zacharias Isaac is holding 65,840 shares at $619,271 based on the most recent closing price.

Stock Fundamentals for SWAV

Current profitability levels for the company are sitting at:

  • -0.37 for the present operating margin
  • +82.53 for the gross margin

The net margin for ShockWave Medical Inc. stands at -3.85. Equity return is now at value -4.20, with -3.10 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 5.54.

Leave a Comment

Your email address will not be published.

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam